Literature DB >> 8195825

Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.

M Filippi1, G J Barker, M A Horsfield, P R Sacares, D G MacManus, A J Thompson, P S Tofts, W I McDonald, D H Miller.   

Abstract

In a preliminary study, we compared by means of quantitative magnetic resonance imaging (MRI) methods (1) the T2 values and the decay characteristics of chronic brain lesions, (2) the T2 values of normal-appearing frontal white matter (NAWM) and (3) brain lesion volumes in patients with benign and secondary progressive multiple sclerosis (MS) in order to evaluate the mechanisms underlying the development of disability. Eleven clinically definite MS patients with either benign MS (n = 5) or secondary progressive MS (n = 6) were studied. Fifty-two chronic lesions (identified by comparison with MRI scans obtained at least 12 months previously) were identified. The mean T2 of large lesions (cross-sectional area greater than 41 mm2) and of the NAWM was similar in both clinical groups. However, small lesions had higher mean T2 values (P < 0.01) in the benign group, probably at least in part because of partial volume effects. Analysis of large lesions revealed biexponential T2 relaxation in 6 of 8 "secondary progressive" and in 2 of 16 "benign" lesions, perhaps indicating a greater degree of axonal loss in large lesions of patients with secondary progressive MS. Patients with secondary progressive MS had higher (although not significant) total and infratentorial lesion loads than those of the benign group. These preliminary findings suggest, but do not establish, that variations in the extent, site and pathological nature of lesions may all contribute to different patterns of disease evolution in MS.

Entities:  

Mesh:

Year:  1994        PMID: 8195825     DOI: 10.1007/bf00863776

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  The longstanding MS lesion. A quantitative MRI and electron microscopic study.

Authors:  D Barnes; P M Munro; B D Youl; J W Prineas; W I McDonald
Journal:  Brain       Date:  1991-06       Impact factor: 13.501

2.  In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis.

Authors:  H B Larsson; J Frederiksen; L Kjaer; O Henriksen; J Olesen
Journal:  Magn Reson Med       Date:  1988-05       Impact factor: 4.668

Review 3.  Pathology of multiple sclerosis: progression of the lesion.

Authors:  C W Adams
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

4.  Proton nuclear magnetic resonance studies on brain edema.

Authors:  S Naruse; Y Horikawa; C Tanaka; K Hirakawa; H Nishikawa; K Yoshizaki
Journal:  J Neurosurg       Date:  1982-06       Impact factor: 5.115

5.  Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy adults.

Authors:  J W Thorpe; D Kidd; B E Kendall; P S Tofts; G J Barker; A J Thompson; D G MacManus; W I McDonald; D H Miller
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

6.  Magnetic resonance imaging of experimental cerebral oedema.

Authors:  D Barnes; W I McDonald; P S Tofts; G Johnson; D N Landon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

7.  Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis.

Authors:  H B Larsson; J Frederiksen; J Petersen; A Nordenbo; I Zeeberg; O Henriksen; J Olesen
Journal:  Magn Reson Med       Date:  1989-09       Impact factor: 4.668

8.  Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease.

Authors:  D H Miller; G Johnson; P S Tofts; D MacManus; W I McDonald
Journal:  Magn Reson Med       Date:  1989-09       Impact factor: 4.668

9.  Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema.

Authors:  D Barnes; W I McDonald; G Johnson; P S Tofts; D N Landon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

10.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis.

Authors:  A J Thompson; A G Kermode; D Wicks; D G MacManus; B E Kendall; D P Kingsley; W I McDonald
Journal:  Ann Neurol       Date:  1991-01       Impact factor: 10.422

View more
  9 in total

1.  MRI findings in benign multiple sclerosis are variable.

Authors:  Sean J Pittock; John H Noseworthy; Moses Rodriguez
Journal:  J Neurol       Date:  2006-08-29       Impact factor: 4.849

Review 2.  Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

Authors:  M Filippi; M Rovaris; G Comi
Journal:  Ital J Neurol Sci       Date:  1996-12

3.  Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.

Authors:  M Filippi; R Capra; A Campi; B Colombo; F Prandini; N Marcianò; R Gasparotti; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Factor VII deficiency in a mixed breed dog.

Authors:  R Macpherson; J Scherer; M L Ross; P A Gentry
Journal:  Can Vet J       Date:  1999-07       Impact factor: 1.008

5.  Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images.

Authors:  M Rovaris; M Filippi; G Calori; M Rodegher; A Campi; B Colombo; G Comi
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

6.  A spinal cord MRI study of benign and secondary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; B Colombo; C Pereira; V Martinelli; C Baratti; G Comi
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

7.  Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; S Mammi; V Martinelli; T Locatelli; G Scotti; S Amadio; N Canal; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

8.  One year follow up study of primary and transitional progressive multiple sclerosis.

Authors:  V L Stevenson; D H Miller; S M Leary; M Rovaris; F Barkhof; B Brochet; V Dousset; M Filippi; R Hintzen; X Montalban; C H Polman; A Rovira; J de Sa; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

9.  Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.

Authors:  H Kearney; M A Rocca; P Valsasina; L Balk; J Sastre-Garriga; J Reinhardt; S Ruggieri; A Rovira; C Stippich; L Kappos; T Sprenger; P Tortorella; M Rovaris; C Gasperini; X Montalban; J J G Geurts; C H Polman; F Barkhof; M Filippi; D R Altmann; O Ciccarelli; D H Miller; D T Chard
Journal:  Mult Scler       Date:  2013-06-27       Impact factor: 6.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.